Kotaro Shide

3.2k total citations
53 papers, 733 citations indexed

About

Kotaro Shide is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Kotaro Shide has authored 53 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 24 papers in Molecular Biology and 23 papers in Hematology. Recurrent topics in Kotaro Shide's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (34 papers), Kruppel-like factors research (18 papers) and Eosinophilic Disorders and Syndromes (14 papers). Kotaro Shide is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (34 papers), Kruppel-like factors research (18 papers) and Eosinophilic Disorders and Syndromes (14 papers). Kotaro Shide collaborates with scholars based in Japan, Australia and Indonesia. Kotaro Shide's co-authors include Kazuya Shimoda, Takuro Kameda, Haruko Shimoda, Yoko Kubuki, Tadashi Matsuda, Kenji Nagata, Satoru Hasuike, Tomonori Hidaka, Kennosuke Karube and Ayako Kamiunten and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Kotaro Shide

49 papers receiving 722 citations

Peers

Countries citing papers authored by Kotaro Shide

Since Specialization

Citations

This map shows the geographic impact of Kotaro Shide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kotaro Shide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kotaro Shide more than expected).

Fields of papers citing papers by Kotaro Shide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kotaro Shide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kotaro Shide. The network helps show where Kotaro Shide may publish in the future.

Co-authorship network of co-authors of Kotaro Shide

This figure shows the co-authorship network connecting the top 25 collaborators of Kotaro Shide. A scholar is included among the top collaborators of Kotaro Shide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kotaro Shide. Kotaro Shide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils 2021 ·Nature Communications ·Yusuke Kimishima, Tomofumi Misaka, Tetsuro Yokokawa, (unknown), Koki Ueda, Koichi Sugimoto, (unknown), Kazuhiko Nakazato, Takafumi Ishida, Motohiko Oshima, Shuhei Koide, Kotaro Shide, Kazuya Shimoda, Atsushi Iwama, Kazuhiko Ikeda, Yasuchika Takeishi	36
2	Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms 2020 ·Blood ·Kotaro Shide, Takuro Kameda, Ayako Kamiunten, (unknown), Yuki Tahira, Takako Yokomizo‐Nakano, Sho Kubota, Masaya Ono, Kazuhiko Ikeda, Masaaki Sekine, Keiichi Akizuki, Kenichi Nakamura, Tomonori Hidaka, Yoko Kubuki, Hisayoshi Iwakiri, Satoru Hasuike, Kenji Nagata, Goro Sashida, Kazuya Shimoda	10
3	CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ 2020 ·Blood ·Takuro Kameda, Kotaro Shide, Ayako Kamiunten, Yuki Tahira, Masaaki Sekine, Keiichi Akizuki, Tomonori Hidaka, Yoko Kubuki, (unknown), Daisuke Morishita, Kazuya Shimoda	2
4	Monocyte-derived fibrocytes elimination had little contribution on liver fibrosis 2019 ·Hepatobiliary & pancreatic diseases international ·(unknown), Kotaro Shide, (unknown), (unknown), (unknown), Ayako Kamiunten, Takuro Kameda, Kenichi Nakamura, Tadashi Miike, Kazunori Kusumoto, Hisayoshi Iwakiri, Satoru Hasuike, Kenji Nagata, Akira Sawaguchi, Kazuya Shimoda	3
5	Essential thrombocytosis attributed to JAK2-T875N germline mutation 2019 ·International Journal of Hematology ·Makoto Yoshimitsu, (unknown), Yuichiro Uchida, (unknown), (unknown), Yuhei Kamada, Kotaro Shide, Masafumi Ito, Kazuya Shimoda, Kenji Ishitsuka	13
6	The role of driver mutations in myeloproliferative neoplasms: insights from mouse models 2019 ·International Journal of Hematology ·Kotaro Shide	6
7	Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm 2017 ·Anticancer Research ·(unknown), Kotaro Shide, Takuro Kameda, Masaaki Sekine, Ayako Kamiunten, Tomonori Hidaka, Yoko Kubuki, Haruko Shimoda, (unknown), Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, (unknown), Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Kazuya Shimoda	1
8	Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients 2016 ·International Journal of Hematology ·Akira Kitanaka, Katsuto Takenaka, Kotaro Shide, Toshihiro Miyamoto, Tadakazu Kondo, Keiya Ozawa, Mineo Kurokawa, Koichi Akashi, Kazuya Shimoda	8
9	Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms 2015 ·Genomics Data ·Takuro Kameda, Kotaro Shide, (unknown), Ayako Kamiunten, Masaaki Sekine, Tomonori Hidaka, Yoko Kubuki, Goro Sashida, Kazumasa Aoyama, Makoto Yoshimitsu, (unknown), Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Atsushi Iwama, Akira Kitanaka, Kazuya Shimoda	3
10	TET2 Mutation in Adult T-Cell Leukemia/Lymphoma 2015 ·Journal of Clinical and Experimental Hematopathology ·Kazuya Shimoda, Kotaro Shide, Takuro Kameda, Tomonori Hidaka, Yoko Kubuki, Ayako Kamiunten, Masaaki Sekine, Keiichi Akizuki, Haruko Shimoda, (unknown), Kenichi Nakamura, (unknown), Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, (unknown), Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Akira Kitanaka	16
11	Effect of NS-018, a selective JAK2V617F inhibitor, in a murine model of myelofibrosis 2014 ·Blood Cancer Journal ·Yohei Nakaya, Kotaro Shide, H. Naito, (unknown), Takekazu Horio, Jun Miyake, Kazuya Shimoda	22
12	JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation 2010 ·British Journal of Haematology ·(unknown), Katsuto Takenaka, Takuro Kuriyama, Kotaro Shide, (unknown), Yoshikane Kikushige, Shingo Urata, Takuji Yamauchi, Chika Iwamoto, Haruko Shimoda, Toshihiro Miyamoto, Koji Nagafuji, Junji Kishimoto, Kazuya Shimoda, Koichi Akashi	43
13	p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation 2009 ·Biochemical and Biophysical Research Communications ·(unknown), Ai Kimura, Kotaro Shide, Kazuya Shimoda, Masashi Murakami, Hiromi Ito, (unknown), Kayo Yoshida, (unknown), Katsuro Hagiwara, Akira Takagi, Tetsuhito Kojima, Motoshi Suzuki, Akihiro Abe, T Naoe, Takashi Murate	17
14	The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan 2009 ·European Journal Of Haematology ·Tomonori Hidaka, Kotaro Shide, Haruko Shimoda, (unknown), Keiko Toyama, (unknown), (unknown), Kenji Nagata, Katsuto Takenaka, Koichi Akashi, Takashi Okamura, Yoshiyuki Niho, Hideaki Mizoguchi, Mitsuhiro Omine, Keiya Ozawa, Mine Harada, Kazuya Shimoda	18
15	Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F 2007 ·Leukemia ·Kotaro Shide, Haruko Shimoda, (unknown), Kennosuke Karube, Takuro Kameda, K Takenaka, S. Oku, (unknown), (unknown), Yoko Kubuki, Kazunori Kusumoto, Satoru Hasuike, Yoshihiro Tahara, Kenji Nagata, Tadashi Matsuda, Koichi Ohshima, M Harada, Kazuya Shimoda	133
16	The Effect of Anabolic Steroids on Anemia in Myelofibrosis with Myeloid Metaplasia: Retrospective Analysis of 39 Patients in Japan 2007 ·International Journal of Hematology ·Kazuya Shimoda, Kotaro Shide, (unknown), Takashi Okamura, Naoki Harada, Naoko Kinukawa, Kazuma Ohyashiki, Yoshiyuki Niho, Hideaki Mizoguchi, Mitsuhiro Omine, Keiya Ozawa, (unknown)	26
17	Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence 2006 ·Leukemia Research ·Kotaro Shide, Kazuya Shimoda, (unknown), (unknown), (unknown), Akihiko Numata, Fumihiko Ishikawa, Katsuto Takenaka, Ken Yamamoto, Tadashi Matsuda, (unknown)	9
18	A Novel Mutation in the Juxtamembrane Intracellular Sequence of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Gene in a Patient with Severe Congenital Neutropenia Augments G-CSF Proliferation Activity but Not through the MAP Kinase Cascade 2005 ·International Journal of Hematology ·Toshihiro Yokoyama, Seiichi Okamura, Yoshinobu Asano, (unknown), Akihiko Numata, (unknown), Kotaro Shide, Hitoshi Nakashima, Taisuke Kanaji, Yuichi Sekine, Yumi Mizuno, Jun Okamura, Tadashi Matsuda, Mine Harada, Yoshiyuki Niho, Kazuya Shimoda	4
19	Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis 2005 ·Leukemia Research ·(unknown), (unknown), Kazuya Shimoda, Kennosuke Karube, (unknown), Akihiko Numata, Kotaro Shide, Tadashi Matsuda, (unknown), Mine Harada	44
20	Signal Transducers and Activators of Transcription 3 Augments the Transcriptional Activity of CCAAT/Enhancer-binding Protein α in Granulocyte Colony-stimulating Factor Signaling Pathway 2005 ·Journal of Biological Chemistry ·Akihiko Numata, Kazuya Shimoda, Kenjiro Kamezaki, (unknown), (unknown), Kotaro Shide, Kouji Kato, Toshihiro Miyamoto, Yoshihiro Yamashita, Yasuo Oshima, Hideaki Nakajima, Atsushi Iwama, Kenichi Aoki, Ken Takase, Hisashi Gondo, Hiroyuki Mano, Mine Harada	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact